Clinical Trial Update: RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms [Phase 2]

View source ↗

Summary

Phase 2 trial update for RVU120 in anemia associated with lower-risk myelodysplastic syndromes. The study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• RVU120 (SEL120)

Snippet

Sponsor: GCP-Service International West GmbH | Conditions: Low Risk Myelodysplastic Syndromes | Phase 2 | Status: ACTIVE_NOT_RECRUITING